The move higher in shares of Geron (GERN) is being attributed to a Johnson & Johnson (JNJ) job opening on LinkedIn for an “EMEA Strategic Pricing Manager” role that would “also be accountable for shaping our pricing approach for Imetelstat.” The two companies currently have a partnership for Imetelstat and J&J is expected to make a decision on potentially continuing the pact in Q3, according to Bloomberg. Geron in early trading is up 25%, or $1.01, to $5.04. STAT’s Adam Feuerstein weighed in via Twitter: “$GERN trading +30% on a JNJ job posting that mentions imetelstat. Yes, it’s that ridiculous. Summer Fridays!”
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.